Cargando…

Rifampin for Staphylococcal Prosthetic Joint Infection: Do We Still Need a Randomized Controlled Trial?

Detalles Bibliográficos
Autores principales:	Scheper, Henk, De Boer, Mark G J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994587/ https://www.ncbi.nlm.nih.gov/pubmed/34402881 http://dx.doi.org/10.1093/cid/ciab704

Ejemplares similares

691 Rifampin in the Treatment of Staphylococcal Prosthetic Joint Infections
por: Parsaei, Shadi, et al.
Publicado: (2014)

Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial
por: Karlsen, Øystein Espeland, et al.
Publicado: (2020)

Adjunctive Rifampin Following Debridement and Implant Retention for Staphylococcal Prosthetic Joint Infection: Is it Effective if not Combined With a Fluoroquinolone?
por: Cortés-Penfield, Nicolás W, et al.
Publicado: (2022)

Comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
por: Scheper, Henk, et al.
Publicado: (2020)

Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis
por: Ryder, Jonathan H, et al.
Publicado: (2022)

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Correction to: Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis
Publicado: (2023)

927 Rifampin for Surgically Treated Staphylococcal Infective Endocarditis
por: Shrestha, Nabin, et al.
Publicado: (2014)

395. Safety and Tolerability of Rifampin in Staphylococcal Orthopedic Infections
por: Miller, Andy O, et al.
Publicado: (2019)

Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
por: Leijtens, Borg, et al.
Publicado: (2017)

If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study
por: Beldman, Mark, et al.
Publicado: (2021)

Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin
por: Legout, Laurence, et al.
Publicado: (2014)

1210. Staphylococcal Acute Post-Operative Prosthetic Joint Infection (PJI) Treated With “DAIR” (Debridement and Implant Retention) and Impact of Rifampin: A Retrospective Cohort Study in France
por: Becker, Agathe, et al.
Publicado: (2018)

Outcome of Debridement, Antibiotics, and Implant Retention for Staphylococcal Hip and Knee Prosthetic Joint Infections, Focused on Rifampicin Use: A Systematic Review and Meta-Analysis
por: Scheper, H, et al.
Publicado: (2021)

Correction to: If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study
por: Beldman, Mark, et al.
Publicado: (2022)

Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates
por: van der Lugt, N Margreth, et al.
Publicado: (2010)

Effectiveness of Different Antimicrobial Strategies for Staphylococcal Prosthetic Joint Infection: Results From a Large Prospective Registry-Based Cohort Study
por: Scheper, Henk, et al.
Publicado: (2022)

Treatment of prosthetic joint infections due to Propionibacterium
Publicado: (2016)

Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection
por: Carli, Alberto V., et al.
Publicado: (2020)

Coxiella burnetti prosthetic joint infection in an immunocompromised woman: iterative surgeries, prolonged ofloxacin-rifampin treatment and complex reconstruction were needed for the cure
por: Miailhes, Patrick, et al.
Publicado: (2021)

Is Gram staining still useful in prosthetic joint infections?
por: Wouthuyzen-Bakker, Marjan, et al.
Publicado: (2019)

321. Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection
por: Miller, Andy, et al.
Publicado: (2018)

Why do we still need participatory technology assessment?
por: Hennen, Leonhard
Publicado: (2012)

Do we still need renal biopsy in lupus nephritis?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?
por: Semsarian, Caitlin R., et al.
Publicado: (2022)

Which is the best treatment for prosthetic joint infections due to Propionibacterium acnes: need for further biofilm in vitro and experimental foreign-body in vivo studies?
por: Corvec, Stéphane, et al.
Publicado: (2016)

We do not need a third mechanistic descriptor for chronic pain states! Not yet
por: Granan, Lars-Petter
Publicado: (2017)

Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
por: Chang, Amy T, et al.
Publicado: (2020)

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
por: Padari, Helgi, et al.
Publicado: (2016)

Cryoballoon ablation: Do we still need real-time recordings?
por: Bisignani, Antonio, et al.
Publicado: (2021)

What do we still need to learn on digitally assessed biomarkers?
por: Acs, Balazs, et al.
Publicado: (2021)

Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
por: Isaguliants, Maria, et al.
Publicado: (2022)

Prosthetic Shoulder Joint Infection by Cutibacterium acnes: Does Rifampin Improve Prognosis? A Retrospective, Multicenter, Observational Study
por: Vilchez, Helem H., et al.
Publicado: (2021)

The importance of appropriate diagnostics in prosthetic joint infection: letter to the editor of BMC musculoskeletal disorders
por: McNally, Martin, et al.
Publicado: (2021)

Telesurgery is promising but still need proof through prospective comparative studies
por: Stark, Michael, et al.
Publicado: (2012)

Why Do We Still Need Large Scale Clinical Trial: The Case of n−3 PUFA
por: Marchioli, Roberto, et al.
Publicado: (2012)

Opinion: PARP inhibitors in cancer—what do we still need to know?
por: Wicks, Andrew J., et al.
Publicado: (2022)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023)

Do we still need to talk about maternal morbidity and near miss?
por: Fonseca, Sandra Costa
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8529nnhrvddjnev9sbnq7jvalv